BioCentury
ARTICLE | Clinical News

Boostrix regulatory update

May 9, 2005 7:00 AM UTC

FDA approved a BLA for Boostrix, a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis booster vaccine, to treat bacterial infetions in individuals aged 10 to 18. ...